menu ☰
menu ˟

Novel treatment approach shows promise in cannabis dependence

07 Dec 2018
A novel fatty acid amide hydrolase inhibitor known as PF-04457845 reduced cannabis withdrawal symptoms and use among men with cannabis dependence or cannabis use disorder, according to data from a phase 2a trial published in The Lancet Psychiatry.“...

Click here to view the full article which appeared in Psychiatry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.